Financial Summary (Consolidated) for the Fiscal Year Ending March 2026 【Japanese Standards】

Overview of Financial Results

For the fiscal year ending March 2026, consolidated net sales were ¥81.308 billion (a 1.0% increase YoY). Although sales to the B&P market were sluggish due to Europe's challenging economic environment, sales to the Healthcare market showed signs of recovery mainly in Europe, North America, and China. Operating profit was ¥2.365 billion (a 36.2% decrease YoY), and ordinary income was ¥3.772 billion (a 17.2% decrease). However, as a special gain, ¥7.999 billion was recognized from the partial sale of policy-held shares and pure investment purpose shares. Net income attributable to owners of the parent increased by 76.5% YoY to ¥7.323 billion.

Segment Trends and Future Outlook

The B&P market continues to face a tough environment mainly in Germany, and efforts are underway to clear inventory of older products and boost sales through new product launches. The Healthcare market is expected to recover sales overseas including Japan, while the Creative Work market aims to expand sales with a broad product lineup despite Europe's challenging environment. The V&S market remains strong with ongoing order accumulation driven by robust demand, and continued growth is anticipated. For the fiscal year ending March 2027, the company plans to achieve net sales of ¥85.000 billion (up 4.5% YoY) and operating profit of ¥3.300 billion (up 39.5% YoY).